Happy World Kidney Day!

Happy #NephMadness Eve to all who celebrate!

1️⃣ We are pleased to announce the publication of the KDIGO 2025 ADPKD Guideline! This first-ever KDIGO guideline focused on a rare kidney disease provides practical tools to improve diagnosis, care, and treatment. Read the news release: kdigo.co/2025-ADPKD-G... #ADPKD

1/n HydrANCAzine (hydralazine-induced ANCA-associated vasculitis has turn into an important cause of crescentic glomerulonephritis. Wonder how does hydralazine do it? Here is a tweetorial (BlueSkytorial?). I’ll start with an animation that summarizes and simplifies a proposed mechanism.

📟 Consulted a few times last week for, “Is this an RTA?” and my knee-jerk answer is “No”. 📖 The truth is that RTAs are rare though we talk about them a lot in med school. So here are some causes of a non-gap acidosis that are more common than an RTA. A 🧵 #nephsky #emimcc #icusky

Celebrating the holidays together! Love our team ❤️ @drjakenysather.bsky.social @zacharysmithmd.bsky.social @jayminbpmd.bsky.social

Check out #KDIGOGems 💎 a dynamic new program offering virtual education on the latest @gokdigo.bsky.social Guidelines #Nephpearls Register here 👉 gems-gd.org/home

1/n happy to share a recent publication from Ochsner Nephrology at Kidney International Reports @kireports.bsky.social Nice visual abstract by Priti Meena. Link here: www.kireports.org/article/S246... But let me tell you the story a little bit…

Welcome new University of Cincinnati nephro fellows. A fun, rewarding, always interesting experience awaits. Excited to meet everyone. @gudnephron.bsky.social @drjakenysather.bsky.social

New today - @thelancet.bsky.social DM/Endo GLP1RAs and kidney/CV outcomes - SR from @sunilbadve.bsky.social Tuttle, Perkovic et al www.thelancet.com/journals/lan... ($🔒) - with/out DM - kidney outcomes (not albuminuria)

👉Before we start, a few reminders! Are you new to #NephJC? Not sure what to do or how this works? Here is a quick rundown. 💡Remember: the simplest rule is to be kind and inclusive while you use your wit! ⏰ We’ll get started in 15min!

Had a great time with everyone @NKFCincy #DriveForDialysis. Look forward to surprising some patients with some goodies! @govil_amit @UCKidney #NKF

Join for the Onconeph education series #onconeph

So folks, one of my primary responsibilities for RPA is to monitor the U.S. Medicare Fee Schedule for nephrology; this will be a thread with key highlights from the 2025 fee schedule which came out November 1. To be transparent, much of this was sent to RPA members yesterday.

The most effective pharmacological and hemodynamic intervention for the treatment of hepatorenal syndrome #HRS is a substantial MAP raise, as illustrated in this case example